According to the health department's annual report, companies paid $5.3 billion in rebates for PBS-listed medicines in 2023-24, while growth in net spending on the program was well below inflation.
Latest Video
New Stories
-
The 'Week in Review' Podcast - 1 November
November 1, 2024 - - Podcast -
Liz Selby goes from acting to permanent head of Sanofi's local pharmaceutical business
November 1, 2024 - - Latest News -
Arrotex partners with Juniper to deliver new rare blood cancer treatment
November 1, 2024 - - Latest News -
Pharmac proposes expanding access to Amgen's osteoporosis biologic
November 1, 2024 - - Latest News -
Rebates are by far the fastest growing component of PBS spend
October 31, 2024 - - Latest News -
This circular and semantic argument ends with one conclusion - a submission cap
October 31, 2024 - - Latest News -
This would be the most significant change in PBS decision-making in over 30 years
October 31, 2024 - - Latest News